Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?

Blood Pressure Monitoring

Volumn 12, Issue 3, 2007, Pages 133-139

  Afsar, Baris ^a,b   Sezer, Siren ^a   Elsurer, Rengin ^a   Ozdemir, Fatma Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Essential hypertension; Homeostasis model assessment; Insulin resistance; Nocturnal nondipping; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ANALYTIC METHOD; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; BLUNTED NOCTURNAL HYPOTENSION; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT INDEX; HUMAN; HYPOTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 34248361113     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e3280b08379     Document Type: Article

References (28)

1. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-381.
2. Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care 1997; 20:1744-1766.
3. Nosadini R, Solini A, Velussi M, Muollo B, Frigato F, Sambataro M, et al. Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 1994; 43:491-499.
4. Della Mea P, Lupia M, Bandolin V, Guzzon S, Sonino N, Vettor R, Fallo F. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am J Hypertens 2005; 18:30-35.
5. Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens Suppl 1991; 9:S42-S44.
6. Pickering TG, Devereux RB. Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk. Am Heart J 1987;114 (4 Pt 2):925-928.
7. Davidson MB, Vidt DG, Hoogwerf BJ, Brotman DJ. Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus. Am J Cardiol 2005; 95:123-126.
8. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Parving HH. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995; 44:783-789.
9. Bjorklund K, Lind L, Andren B, Lithell H. The majority of nondipping men do not have increased cardiovascular risk: a population-based study. J Hypertens 2002; 20:1501-1506.
10. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes 1998; 47:1501-1506.
11. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-1197.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
13. Lebovitz HE. Insulin resistance and the insulin resistance syndrome. In: Lebowitz HE, editor. Clinician's manual on insulin resistance. London: Science Press Ltd; 2002. pp. 1-15.
14. O'Brien E, Pickering T, Asmar R, Myers M, Parati G, Staessen J, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Pressure Monitoring 2002; 7:3-17.
15. Jones SC, Bilous M, Winship S, Finn P, Goodwin J. Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices. Blood Pressure Monitoring 2004; 9:219-223.
16. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97:2601-2610.
17. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension 1993; 22:292-299.
18. Tedde R, Sechi LA, Marigliano A, Pala A, Scano L. Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertens. 1989; 2 (3 Pt 1):163-170.
19. Randeree HA, Omar MA, Motala AA, Seedat MA. Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 1992; 15:1258-1263.
20. Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T, Yoshimatsu H. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26:669-676.
21. Julius S. Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993; 21 (6 Pt 2):886-893.
22. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321:412-419.
23. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 16:949-961.
24. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 2004; 286:H1597-H1602.
25. Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998; 352:670-671.
26. Nakano S, Ishii T, Kitazawa M, Kigoshi T, Uchida K, Morimoto S. Altered circadian blood pressure rhythm and progression of diabetic nephropathy in non-insulin dependent diabetes mellitus subjects: an average three year follow-up study. J Invest Med 1996; 44:247-253.
27. Nakano S, Uchida K, Kigoshi T, Azukizawa S, Iwasaki R, Kaneko M, Morimoto S. Circadian rhythm of blood pressure in normotensive NIDDM subjects. Its relationship to microvascular complications. Diabetes Care 1991; 14:707-711.
28. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987; 79:790-800.